donepezil has been researched along with sb 742457 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badange, RK; Bandyala, TR; Benade, V; Bhatta, V; Bhyrapuneni, G; Bojja, K; Goyal, V; Jasti, V; Jayarajan, P; Kambhampati, RS; Mohammed, AR; Nirogi, R; Palacharla, RC; Reballi, V; Saraf, SK; Shinde, A; Subramanian, R | 1 |
Bojarski, AJ; Canale, V; Chaumont-Dubel, S; Fülöpová, V; Funk, P; Koczurkiewicz, P; Kos, T; Lemrová, B; Marin, P; Pękala, E; Popik, P; Satała, G; Soural, M; Vanda, D; Zajdel, P | 1 |
Bojarski, AJ; Bugno, R; Dubiel, K; Hogendorf, A; Hogendorf, AS; Kalinowska-Tłuścik, J; Knutelska, J; Krawczyk, M; Kurczab, R; Lenda, T; Matłoka, M; Moszczyński-Pętkowski, R; Nikiforuk, A; Pieczykolan, J; Pietruś, W; Pilarski, B; Popik, P; Satała, G; Staroń, J; Wieczorek, M; Zajdel, P | 1 |
Dixon, R; Gold, M; Hopton, G; Hunter, J; Jacobs, G; Maher-Edwards, G; Williams, P | 1 |
Jayarajan, P; Nirogi, R; Shinde, A | 1 |
1 trial(s) available for donepezil and sb 742457
Article | Year |
---|---|
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cholinesterase Inhibitors; Cognition; Donepezil; Female; Humans; Indans; Male; Middle Aged; Piperidines; Quinolines; Serotonin Antagonists; Sulfones | 2011 |
4 other study(ies) available for donepezil and sb 742457
Article | Year |
---|---|
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT
Topics: Administration, Oral; Alzheimer Disease; Animals; Drug Discovery; Humans; Indoles; Male; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 2017 |
Novel non-sulfonamide 5-HT
Topics: Animals; Cognition; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Imidazoles; Male; Molecular Structure; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Structure-Activity Relationship | 2018 |
2-Aminoimidazole-based antagonists of the 5-HT
Topics: Animals; Cells, Cultured; Cognitive Dysfunction; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Hep G2 Cells; Humans; Imidazoles; Male; Models, Molecular; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin Antagonists; Structure-Activity Relationship | 2019 |
Effect of olanzapine on scopolamine induced deficits in differential reinforcement of low rate 72s (DRL-72s) schedule in rats: involvement of the serotonergic receptors in restoring the deficits.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Cholinesterase Inhibitors; Conditioning, Operant; Donepezil; Haloperidol; Impulsive Behavior; Indans; Male; Muscarinic Antagonists; Olanzapine; Piperidines; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reinforcement, Psychology; Scopolamine; Serotonin Antagonists; Sulfones | 2013 |